GMP vs cGMP in Pharma: Requirements, FDA vs EU Differences, and a Facility Compliance Checklist

The short answer: GMP and cGMP describe the same body of requirements. "cGMP" — current Good Manufacturing Practice — is the term used in U.S. law (21 CFR Parts 210 and 211), where "current" means your facility, equipment, and control systems must be up to date with today's standards, not merely with rules written decades ago. EU, WHO, and PIC/S regulators simply say "GMP". In practice, buyers and project teams treat the two as synonyms; what actually differs is which regulator's rulebook — the FDA's or the EU's EudraLex Volume 4 — your facility must satisfy.

If you are specifying a cleanroom, ordering equipment, or qualifying suppliers for a pharmaceutical project, that distinction matters commercially: the terminology tells you which inspection regime you are designing for, and the checklist at the end of this article tells you what to demand from your vendors.

What Is GMP?

Good Manufacturing Practice (GMP) is the system of rules that governs how medicines are produced and controlled, so that every batch is consistently safe, effective, and of the stated quality. It covers the parts of an operation that determine quality:

• Facility design, construction, and maintenance
• Equipment qualification, calibration, and cleaning
• Personnel training, hygiene, and gowning
• Documentation of every process step
• Controls over raw materials, production, packaging, and laboratory testing
• A quality system that investigates deviations and drives corrective action

The legal basis depends on the market. In the United States, the core regulations are 21 CFR Part 210 (general provisions) and Part 211 (finished pharmaceuticals), which spell out requirements from buildings and ventilation (§211.42–211.58) through equipment, production controls, laboratory controls, and records. In the European Union, the equivalent is EudraLex Volume 4, adopted under Directive 2003/94/EC. The World Health Organization publishes its own GMP guide used for prequalification and in many emerging markets, and PIC/S — the Pharmaceutical Inspection Co-operation Scheme — harmonizes inspection standards across more than 50 participating authorities, so an inspection outcome in one PIC/S country carries weight in others.

What Does "Current" in cGMP Actually Mean?

The FDA's regulations use the phrase "current good manufacturing practice", and the word "current" is doing real work. It tells manufacturers that compliance is measured against what is considered good practice today. The FDA states it plainly: companies are required to maintain facilities and controls that are up to date with modern standards, using equipment and methods that current science and industry practice support.

Two practical consequences follow:

• A cleanroom that passed inspection years ago is not grandfathered in. Control systems, monitoring technology, and contamination-control expectations evolve; regulators expect facilities to evolve with them. The 2023 revision of EU GMP Annex 1 is a live example — it introduced the Contamination Control Strategy (CCS) as an explicit requirement for sterile manufacturing, and facilities across the industry had to document one to stay compliant.
• "cGMP" is not a separate, stricter certificate. A supplier claiming "cGMP certified" is either referring to FDA compliance or using loose marketing language; there is no standalone cGMP certification body. What you should ask for instead is evidence: which regulations they design and test to, and what documentation package comes with the equipment.

Note that European regulators do not use the term "cGMP" at all — EudraLex says "GMP". When a specification sheet or article uses both terms interchangeably, it is referring to the same requirement set from two regulatory vocabularies.

GMP vs cGMP: The Practical Difference

FDA GMP vs EU GMP: Where the Requirements Actually Differ

Manufacturers selling into both markets build to both rulebooks. For a project team, the differences that reach into facility and equipment decisions are these:

The 2023 Annex 1 revision deserves specific attention from anyone building or upgrading a sterile facility, because it converted several former expectations into hard requirements:

• Contamination Control Strategy (CCS): manufacturers must implement and actively review a documented CCS that ties together design, procedural, technical, and organizational controls across the facility.
• Requalification intervals: the maximum interval for requalification of Grade A and Grade B areas is now 6 months (Annex 1 point 4.32) — a direct cost line for anyone operating classified cleanrooms.
• Disinfection: disinfectants and detergents used in Grade A and B areas must be sterile prior to use, and the disinfection process itself must be validated.

The revised Annex 1 is effectively identical to PIC/S Annex 1 (with minor editorial differences), so designing to it positions a facility for PIC/S-participating markets well beyond the EU.

What GMP/cGMP Means for Your Cleanroom and Equipment

Regulations tell you what to control; the cleanroom is where the controlling physically happens. A few translation points from rulebook to hardware:

Air supply and terminal filtration. Grade A zones and ISO Class 5 backgrounds are delivered by unidirectional (laminar) airflow through HEPA-filtered terminals. Most pharmaceutical projects use fan filter units (FFUs) as the primary air supply device, and the choice of H13 vs H14 HEPA filter class directly determines whether a zone can hold its class in operation. For aseptic core areas, a laminar flow ceiling system with gel-sealed HEPA terminals is the standard approach; coverage ratio and layout matter as much as the hardware, and FFU ceiling layout design for ISO Class 5 cleanrooms is worth reading before specifying quantities.

Material and personnel flow. GMP demands segregation of flows to prevent cross-contamination. In practice that means VHP sterilization pass boxes for material transfer into Grade A/B areas, and air shower pass boxes at lower-grade boundaries.

Containment at the process step. Weighing and dispensing of active powders is a classic GMP observation point; a controlled environment weighing and dispensing booth with downward displacement airflow protects both the operator and the product.

Gowning discipline. The 2023 Annex 1 tightened expectations around gowning and garment management. HEPA-filtered laminar flow garment cabinets keep cleanroom garments from becoming a contamination source between laundering and use.

Environmental systems as a whole. Temperature, humidity, and differential pressure must be continuously controlled and monitored — the vocabulary of MAU, AHU, RCU, and FFU in a cleanroom HVAC system is worth knowing before you talk to a cleanroom contractor, because these are the units your monitoring points will hang on.

cGMP Checklist for Procurement and Project Teams

Use this when specifying a facility or qualifying equipment vendors. Items marked "documentation" are what separate a compliant supplier from a cheap one.

Facility and equipment qualification:

1. Cleanroom classification documented for "at rest" and "in operation" states, not just as-built
2. DQ/IQ/OQ protocol structure agreed before contracts are signed
3. HEPA installation leak test (PAO/DOP) included in OQ scope
4. Airflow visualization (smoke studies) for unidirectional zones
5. Pressure cascade map across all classified and supporting areas
6. Recovery-time test data after particle challenge
7. Requalification schedule in the maintenance contract — Grade A/B at intervals of 6 months or less
8. Material certificates for product-contact surfaces (typically 304/316L stainless)
9. Cleaning and disinfection validation plan, including sterile disinfectants for Grade A/B
10. Monitoring system design: particle, differential pressure, temperature, humidity, with alarm limits and data retention

Supplier qualification:

1. Which regulatory framework the supplier designs and tests to (FDA/EU/WHO/PIC/S) — stated, not implied
2. Full documentation package available: functional specifications, test reports, calibration certificates, operation and maintenance manuals
3. Factory acceptance test (FAT) and site acceptance test (SAT) offered as standard scope
4. Traceability: serial numbers, filter batch records, fan and motor datasheets
5. Spare parts availability and stated lead times — a pass box that idles a Grade A room for six weeks waiting for a door interlock part is a compliance problem, not just a logistics one
6. References from facilities inspected by your target regulator
7. Change control: the supplier must notify you of design changes affecting qualified performance

Data Integrity and Documentation

Since electronic records became the norm, data integrity has been one of the most-cited categories of GMP inspection findings worldwide. The framework most inspectors work from is ALCOA+ — records must be Attributable, Legible, Contemporaneous, Original, and Accurate, plus Complete, Consistent, Enduring, and Available.

For facility and equipment buyers, two regulations anchor this: 21 CFR Part 11 (U.S.) and EU GMP Annex 11 (computerised systems). Practically, it means your environmental monitoring system, and any equipment with a control interface, should support user access levels, audit trails, and controlled data export — decisions that are far cheaper to make at specification stage than to retrofit.

Common cGMP Inspection Findings

Patterns that recur across published FDA warning letters and EU inspection reports include:

• Inadequate investigation of deviations and out-of-specification results
• Environmental monitoring gaps — insufficient locations, missed excursions, or trending that never triggers action
• Cleaning validation that does not reflect actual worst-case use
• Facility maintenance issues: damaged surfaces, unsealed penetrations, HVAC deficiencies
• Data integrity failures: shared logins, missing audit trails, deleted or backdated records

Every one of these is either prevented or exposed by how well your facility was specified and documented in the first place — which is why experienced project teams treat the qualification documentation package as a primary selection criterion, not an afterthought.

Frequently Asked Questions

Is cGMP a separate certification from GMP?
No. "cGMP" is the FDA's statutory wording for the same requirement set. There is no standalone cGMP certification; what exists is compliance with specific regulations (21 CFR 210/211 in the U.S., EudraLex Volume 4 in the EU), verified by the relevant inspectorate.

Does the EU use the term cGMP?
No. European legislation and EudraLex Volume 4 use "GMP" only. The "current" concept is embedded in EU expectations of ongoing control and review rather than spelled out in the name.

What is the difference between GMP and ISO 14644?
ISO 14644 is a technical standard that defines and measures air cleanliness classes (e.g., ISO 5). GMP is a regulatory framework for producing medicines. GMP cleanrooms use ISO 14644 classes as the measurement vocabulary — EU GMP Grades A–D map broadly onto ISO Classes 5–8 — but GMP adds everything ISO does not cover: personnel, documentation, quality systems, and inspection.

Who enforces GMP?
In the U.S., the FDA. In the EU, national competent authorities coordinated by the EMA. The WHO runs prequalification for its programs. PIC/S harmonizes standards across participating inspectorates, and the EU–U.S. mutual recognition agreement means each side can rely on the other's GMP inspections.

How often must Grade A/B cleanrooms be requalified?
Under the revised EU GMP Annex 1 (point 4.32), the maximum requalification interval for Grade A and B areas is 6 months, with requalification also required after remedial work or changes to equipment, facility, or process.

From Compliance Requirements to a Working Facility

GMP and cGMP frameworks tell you what must be true about your facility. Turning that into a delivered cleanroom — classified, documented, and inspectable — is an engineering project: airflow design, pressure cascades, material and personnel flows, terminal filtration, and a qualification documentation package that satisfies both your QA team and the inspector.

GCC Cleanroom designs and delivers pharmaceutical cleanroom projects and GMP-supporting equipment — from FFU systems and laminar flow ceilings to pass boxes, weighing booths, and garment storage — with the design documentation, test data, and FAT/SAT scope that cGMP projects require. If you are planning a facility or upgrading an existing one, contact our engineering team to request specifications and qualification documentation for your project scope.